Tshwane:President Cyril Ramaphosa has announced the opening of the CSIR FuturePHARMA facility, emphasizing its potential to enhance South Africa's ability to develop vaccines and medicines domestically, thus preparing for future pandemics.

According to South African Government News Agency, President Ramaphosa underscored the lessons learned from the COVID-19 pandemic, particularly the need for health sovereignty and reducing dependency on foreign pharmaceutical products. The FuturePHARMA facility will enable South Africa to conduct essential research and develop necessary products to swiftly address future health emergencies.

Reflecting on the COVID-19 pandemic, President Ramaphosa noted that despite South Africa's involvement in vaccine development, the country's ability to fully leverage its scientific capabilities was hindered by existing international contracts. FuturePHARMA aims to change this by providing a local platform to support pharmaceutical development.

The President also pointed out the existing leadership and scientific expertise within South Africa's research ecosystem, with Health Minister Dr. Aaron Motsoaledi and Science, Technology and Innovation Minister Dr. Blade Nzimande leading the efforts in medicines development and research innovation, respectively.

FuturePHARMA is designed to integrate these capabilities with specialized infrastructure, supporting pharmaceutical process development, technology transfer, and advancement towards clinical and commercial pathways. The facility will also be accessible to private companies and entrepreneurs, allowing them to utilize the infrastructure and expertise, which might otherwise be cost-prohibitive.

The facility's open-access model is expected to bolster the country's pharmaceutical industry and facilitate the translation of South African innovation into commercial products. President Ramaphosa indicated that this initiative aims not just to strengthen national capabilities but to extend these benefits to the entire African continent.

'This is a game changing facility. It's going to enable us to be pandemic-ready whenever there are pandemics of any type, will be able to have a facility that is ready for the immediate research and development of all the capabilities that we will need to develop vaccines,' the President said.